Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

JohnSJ

(92,243 posts)
Thu Mar 11, 2021, 10:22 AM Mar 2021

Oxford-AstraZeneca: Denmark suspends vaccine 'as a precaution'

"Denmark has temporarily halted use of the Oxford-AstraZeneca vaccine as a precaution, after reports of a small number of blood clots and one death.

The Danish health authority said it was too early to say whether there was a link to the AstraZeneca vaccine.

Austria earlier stopped using a batch of the drug, prompting the EU medicines agency to say there was no indication the vaccine caused blood clots.

The company says its safety has been studied extensively in clinical trials.

"Patient Safety is the highest priority for AstraZeneca," a spokesperson said.

"Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes Covid-19 Vaccine AstraZeneca."

Peer-reviewed data confirmed it had been "generally well tolerated", the statement added.

The Danish decision came days after Austria suspended use of a particular batch of the drug because a woman died 10 days after taking it. Estonia, Latvia, Lithuania and Luxemburg have also stopped using the batch.

https://www.bbc.com/news/world-europe-56357760

2 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Oxford-AstraZeneca: Denmark suspends vaccine 'as a precaution' (Original Post) JohnSJ Mar 2021 OP
22 case in 3 million vaccinations. That's lottery odds. Probability 0.00000733. I'll risk it. nt Binkie The Clown Mar 2021 #1
AstraZeneca has not yet been approved in the US. LisaL Mar 2021 #2
Latest Discussions»General Discussion»Oxford-AstraZeneca: Denma...